Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
HYPERTENSION | Trending Topics | January 2020
02/06/2020 | Hypertension Trending Topics for January 2020 Level of Physical Activity, Left Ventricular Mass, Hypertension, and Prognosis In Utero Antihypertensive Medication Exposure and Neonatal Outcomes: A Data Linkage Cohort Study
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.
HYPERTENSION | High Impact Papers | Winter 2019
01/24/2020 | Hypertension High Impact Papers for Winter Collection 2019
HYPERTENSION | Live Tweet Chat | November 25, 2019
11/22/2019 | HYPERTENSION, Obesity, High Blood Pressure, and Physical Activity Determine Vascular Phenotype in Young Children
Science News 2019 Scientific Sessions
11/16/2019 | Science News coverage of selected presentations and interviews from AHA's Scientific Sessions 2019. Nov. 16-18, 2019 in Philadelphia, PA.